viDA Therapeutics Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$15M
- Investors
-
4
viDA Therapeutics General Information
Description
Operator of a biopharmaceutical and drugs discovery company intended to promote autoimmune and chronic diseases and assist in the treatment of age-related chronic inflammatory diseases. The company specializes in the research and development of therapeutics targeting granzyme serine proteases that eliminate diseases such as inflammation, disruption of barrier function, and vascular leakage, enabling the healthcare industry to improve the overall medical treatment offered to patients.
Contact Information
Website
www.vidatherapeutics.comCorporate Office
- 887 Great Northern Way
- Unit 125
- Vancouver, British Columbia V5T 4T5
- Canada
Corporate Office
- 887 Great Northern Way
- Unit 125
- Vancouver, British Columbia V5T 4T5
- Canada
viDA Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A) | 01-Jan-2020 | $15M | Completed | Generating Revenue | ||
| 4. Later Stage VC | 10-Jul-2013 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 24-Apr-2013 | Completed | Startup | |||
| 2. Grant | 20-Apr-2010 | $68K | Completed | Startup | ||
| 1. University Spin-Out | 01-Feb-2008 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
viDA Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
viDA Therapeutics Patents
viDA Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190038602-A1 | Granzyme b inhibitor formulations and methods for the treatment of burns | Inactive | 03-Feb-2016 | ||
| US-9458193-B1 | Proline compounds as granzyme b inhibitors | Active | 01-Aug-2014 | ||
| US-20170015706-A1 | Proline compounds as granzyme b inhibitors | Active | 01-Aug-2014 | ||
| US-9969770-B2 | Proline compounds as granzyme b inhibitors | Active | 01-Aug-2014 | ||
| US-20170209608-A1 | Cyclic urea compounds as granzyme b inhibitors | Active | 01-Aug-2014 | A61L2/10 |
viDA Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
viDA Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Nimbus Synergies | Venture Capital | Minority | ||
| BDC Capital | Growth/Expansion | Minority | ||
| Carmanah | Venture Capital | Minority | ||
| The University of British Columbia | University |
viDA Therapeutics FAQs
-
When was viDA Therapeutics founded?
viDA Therapeutics was founded in 2008.
-
Where is viDA Therapeutics headquartered?
viDA Therapeutics is headquartered in Vancouver, Canada.
-
What is the size of viDA Therapeutics?
viDA Therapeutics has 4 total employees.
-
What industry is viDA Therapeutics in?
viDA Therapeutics’s primary industry is Drug Discovery.
-
Is viDA Therapeutics a private or public company?
viDA Therapeutics is a Private company.
-
What is viDA Therapeutics’s current revenue?
The current revenue for viDA Therapeutics is .
-
How much funding has viDA Therapeutics raised over time?
viDA Therapeutics has raised $20.4M.
-
Who are viDA Therapeutics’s investors?
Nimbus Synergies, BDC Capital, Carmanah, and The University of British Columbia have invested in viDA Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
